Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology.
- DOI
- 10.1016/j.jmoldx.2017.11.004
- Published
- 2018-01-23
- Container
- J Mol Diagn
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jmoldx.2017.11.004,
title = {Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology.},
author = {Lindeman NI and Cagle PT and Aisner DL and Arcila ME and Beasley MB and Bernicker EH and Colasacco C and Dacic S and Hirsch FR and Kerr K and Kwiatkowski DJ and Ladanyi M and Nowak JA and Sholl L and Temple-Smolkin R and Solomon B and Souter LH and Thunnissen E and Tsao MS and Ventura CB and Wynes MW and Yatabe Y.},
year = {2018},
journal = {J Mol Diagn},
doi = {10.1016/j.jmoldx.2017.11.004},
url = {https://doi.org/10.1016/j.jmoldx.2017.11.004}
}RIS
TY - JOUR TI - Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology. AU - Lindeman NI AU - Cagle PT AU - Aisner DL AU - Arcila ME AU - Beasley MB AU - Bernicker EH AU - Colasacco C AU - Dacic S AU - Hirsch FR AU - Kerr K AU - Kwiatkowski DJ AU - Ladanyi M AU - Nowak JA AU - Sholl L AU - Temple-Smolkin R AU - Solomon B AU - Souter LH AU - Thunnissen E AU - Tsao MS AU - Ventura CB AU - Wynes MW AU - Yatabe Y. PY - 2018 JO - J Mol Diagn DO - 10.1016/j.jmoldx.2017.11.004 UR - https://doi.org/10.1016/j.jmoldx.2017.11.004 ER -
APA
NI, L., PT, C., DL, A., ME, A., MB, B., EH, B., C, C., S, D., FR, H., K, K., DJ, K., M, L., JA, N., L, S., R, T., B, S., LH, S., E, T., MS, T., CB, V., MW, W., & Y., Y. (2018). Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology.. J Mol Diagn. https://doi.org/10.1016/j.jmoldx.2017.11.004
Source records
- europe-pmc · retrieved 2026-09-27T02:18:16.606Z